Opus Genetics

IRD

3.3250.75% ( -0.025 )

Trading: Jul 28, 10:53:13 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Opus Genetics(IRD) predict that the Revenue is 2.157 M (-50.64%), Miss estimate;the EBIT is -14.36 M (-44.67%), Miss estimate;the EPS is -0.75 (-212.5%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B50.64%

0.00B33.00%

-0.00B17.64%

EBITMiss expectations

-0.01B44.67%

-0.01B29.89%

-0.00B14.78%

EPSMiss expectations

-0.75212.50%

-0.145539.40%

-0.6045251.90%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD